Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol
暂无分享,去创建一个
K. Kirito | K. Takeda | M. Maemondo | T. Ueda | K. Tamura | T. Goto | K. Fujimaki | T. Kiguchi | Y. Kawai | K. Gemba | T. Fujisaki | M. Okamoto | A. Nakajima | M. Kaneko
[1] M. Federico,et al. FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] G. H. Jackson,et al. Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology , 2015, British journal of haematology.
[3] J. Mehta,et al. Risk of Anaphylaxis with Repeated Courses of Rasburicase: A Research on Adverse Drug Events and Reports (RADAR) Project , 2015, Drug Safety.
[4] H. Iwasaki,et al. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study. , 2014, Anticancer research.
[5] Y. Hasegawa,et al. Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome , 2014, SpringerPlus.
[6] M. Lopez‐Olivo,et al. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] R. Day,et al. Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012 , 2013, Drug Safety.
[8] Yan Ge,et al. Generalized multidimensional dynamic allocation method , 2012, Statistics in medicine.
[9] B. Coiffier,et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus , 2010, British journal of haematology.
[10] C. Pui,et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.